J065--Notice of Intent to Sole Source - Enterprise Digital Telepathology Maintenance and Support Services Phillips Healthcare | SAM.gov Opportunity | G2X

J065--Notice of Intent to Sole Source - Enterprise Digital Telepathology Maintenance and Support Services Phillips Healthcare

Solicitation36C10X26A0004Notice typeSpecial Notice

Attachments

3 files

Name	Type	Posted	Actions
https://www.va.gov/opal/sac/contacts.asp	LINK	Feb 24, 2026	Download
36C10X26A0004_1.docx	DOCX	Feb 24, 2026	Download
Sole Source Telepath Service BPA Redact Final.pdf	PDF	Feb 24, 2026	Download

Version History

J065--Notice of Intent to Sole Source - Enterprise Digital Telepathology Maintenance and Support Services Phillips Healthcare

Special Notice36C10X26A0004Feb 24, 2026 · v1

LatestViewing

Opportunity Summary

The Department of Veterans Affairs (VA) Strategic Acquisition Center (SAC), on behalf of the Pathology and Laboratory Medicine (PLM) National Program Office, intends to award a sole source, firm-fixed-price Blanket Purchase Agreement (BPA) to Philips North America, doing business as Philips Healthcare. This requirement covers enterprise digital telepathology maintenance and support services for FDA-cleared systems used in clinical pathology operations across VA Medical Centers nationwide. The scope includes comprehensive preventive and corrective maintenance, replacement parts, software updates, and end-user technical support to ensure uninterrupted Veteran patient diagnosis and care.

The anticipated contract structure consists of a one-year base period followed by four one-year option periods, with an estimated total value between $6 million and $7 million. This acquisition is categorized under NAICS 811210 for Electronic and Precision Equipment Repair and Maintenance and PSC J065 for the maintenance, repair, and rebuilding of medical, dental, and veterinary equipment and supplies. The VA has determined that Philips North America is the only source capable of meeting the requirement due to the proprietary nature of the equipment, original equipment manufacturer (OEM) authority, and federal regulatory requirements.

Identified under solicitation number 36C10X26A0004, this special notice includes two attachments: a redacted justification document and a supplemental Word file. While this is not a request for competitive quotations, interested parties may submit capability statements demonstrating their ability to provide OEM-authorized maintenance and support while maintaining FDA compliance. Responses are due by February 27, 2026, and should be directed to the point of contact, Mr. LaShawn Knight.

Generated by Lumen AI

Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.

Opportunity Summary

Opportunity Details

Response deadline: Feb 27, 2026Expired 99 days ago
NAICS: 811210 (opens in new tab)
PSC: J065 (opens in new tab)
Set aside: —
Published: Feb 24, 2026
Updated: Feb 24, 2026
Agency: VETERANS AFFAIRS, DEPARTMENT OF
Office: VETERANS AFFAIRS, DEPARTMENT OF
Department: —
Source: View on SAM.gov (opens in new tab)

Contact and place of performance

Point of contact: Mr. LaShawn Knight

Place of performance: Not specified

Original Description

Page 2 of 2 NOTICE OF INTENT TO AWARD A SOLE SOURCE BLANKET PURCHASE AGREEMENT Title: Notice of Intent to Sole Source Enterprise Digital Telepathology Maintenance and Support Services Philips Healthcare Description: The Department of Veterans Affairs (VA), Strategic Acquisition Center (SAC), on behalf of the Pathology and Laboratory Medicine (PLM) National Program Office, intends to award a sole source, firm-fixed-price Blanket Purchase Agreement (BPA) to Philips North America dba Philips Healthcare for enterprise digital telepathology equipment maintenance and support services. The proposed action will provide comprehensive preventive maintenance, corrective maintenance, replacement parts, software updates/upgrades, and end-user technical support for Philips digital telepathology systems deployed across VA Medical Centers nationwide. These FDA-cleared systems support mission-critical clinical pathology operations used for Veteran patient diagnosis and care. The anticipated period of performance consists of a one-year base period with four one-year option periods. The total estimated value of this requirement is anticipated to be within the range of $6 million to $7 million over the five-year period of performance. This acquisition is being conducted under the authority of 41 U.S.C. Â§ 1901, as implemented by FAR 12.102(b). The Government has determined that Philips North America is the only responsible source capable of meeting the agency s minimum requirements due to the proprietary nature of the equipment, OEM-controlled maintenance authority, FDA regulatory requirements, and the need to maintain system integrity and uninterrupted clinical operations. This notice is not a request for competitive quotations. However, any interested party that believes it can meet the Government s requirement may submit a capability statement for consideration. Responses must clearly demonstrate the ability to provide OEM-authorized maintenance and support services for Philips digital telepathology systems while maintaining FDA compliance and warranty integrity. For additional details regarding the statutory authority, market research findings, estimated value, and justification for limiting competition, please refer to the attached Justification and Approval (J&A) for Other Than Full and Open Competition.